Prof Gordon Howarth
Professor
School of Animal and Veterinary Sciences
College of Science
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Professor Gordon Howarth leads the University of Adelaide’s Digestive Health Research Group and was continuously supported by Cancer Council Australia Senior Research Fellowships from 2005 to 2014. He also holds Affiliate Professor status in the Gastroenterology Department of the Women’s and Children’s Hospital.
Professor Howarth's research focuses on understanding the mechanisms by which newly-identified bioactive agents act in the intestine. These bioactive agents include probiotics, probiotic-sourced bioactives, prebiotics, synbiotics and bioactive extracts of plant, animal and marine origin. Dr Howarth has developed a wide range of animal models of gastrointestinal disease over a 20-year period. These include models of gastric ulceration, NSAID-enteropathy, chemotherapy-induced mucositis, radiation enteritis, the inflammatory bowel diseases Crohn's disease and ulcerative colitis, and colon cancer. He has utilized these models to demonstrate therapeutic applications for a number of growth factors (eg IGF-I, the subject of Professor Howarth's PhD studies) and bioactive formulations including a whey-derived growth factor extract that is currently undergoing clinical trial for the treatment of oral mucositis. Although Professor Howarth has been an Affiliate title-holder in the University for many years, he joined the University of Adelaide as an Associate Professor in the Discipline of Agricultural and Animal Science in early 2006.
Professor Howarth was supported by Senior Research Fellowships from the Cancer Council for the period 2005-2014. Specific areas of research in the Howarth laboratory include:
- Application of probiotics and probiotic-sourced factors for prevention of bowel inflammation
- The role of medium-chain fatty acids in the development of colon cancer
- Effects of chemotherapy agents on intestinal stem cell expression
- Effects of new bioactive agents on intestinal stem cell expression
- Determining potential efficacy of prebiotics such as FOS/GOS in models of intestinal mucositis and inflammatory bowel disease
- Determining potential efficacy of newly-identified bioactives including dipeptidyl peptidase inhibitors, marine and land mollusc-sourced extracts, wine-sourced procyanidins and herbal extracts for treatment of intestinal mucositis, inflammatory bowel disease and other bowel disorders
- Gut function analyses of congenital disorders such as mucopolysaccharidosis
- Determining gene expression profiles in the intestine
- Nutraceutical modification of animal diets to improve growth performance and animal welfare
Composition of Digestive Health Research Group
Professor Howarth currently leads a team of 22 researchers carrying out novel techniques to assess new treatment strategies for gastrointestinal disease utilising established in vivo model systems. Professor Howarth plays a key role in conceptualisation of research that is undertaken. With respect to his primary research interests, particularly the novel bioactive and animal model studies, he is clearly identified as the principal originator of this research. Moreover, he fulfils the role of a mentor to post-doctoral, research assistant and technical support staff in addition to providing career guidance and counselling to under-graduate, Honours and PhD students. Professor Howarth currently has full access to excellent laboratory space and equipment resources at the Women's and Children's Hospital Gastroenterology Department and at the Roseworthy campus of the University of Adelaide.
Research Collaborations
Professor Howarth has developed and established a significant number of collaborations with other researchers with similar interests in pre-clinical development of bioactive factors for treatment of intestinal disease, or with different applications and hypotheses that require similar technological solutions. The table below lists the collaborations, both with industry and with other researchers, with which he has been involved, with a level of involvement ranging from:
- Providing technical expertise on experimental conditions and analyses required to establish identified animal models of GI disease, or answer questions outside of my direct area of research interest;
- A contribution to the study design, interpretation of data and drafting of manuscripts, or
- Hands-on performance of research studies.
| Chief Collaborator | Institutions | Status | Details Of Project | Level Of Involvement | Industry Partners |
|---|---|---|---|---|---|
|
Dr Ron Cox |
CSIRO, Sydney NSW |
Completed/ 1984 |
Development of a radio-receptor assay for detection of hormone receptors on breast tumours |
Methodological expertise |
|
|
Professor Mathew Vadas |
Institute of Medical and Veterinary Science, Adelaide |
Completed/ 1987 |
Development of a new sensitive assay for anti-nuclear antibodies in human sera |
Methodological expertise |
|
|
Dr John Ballard |
CRC for Tissue Growth and Repair |
Completed/ 1995 |
Identification of insulin-like growth factor-I (IGF-I) as a potent growth stimulator in the gastrointestinal tract |
Methodological expertise |
GroPep Pty Ltd |
|
Dr Chris Goddard |
CRC for Tissue Growth and Repair |
Completed/ 1999 |
Investigations into the physiological role of betacellulin |
Methodological expertise |
GroPep Pty Ltd |
|
Mr Tony Scammell |
Northfield Laboratories, Adelaide |
Completed/ 1999 |
Whey-derived growth factors and treatment of inflammatory bowel disease |
Methodological expertise |
Nutricia Inc |
|
Dr Leanna Read |
CRC for Tissue Growth and Repair |
Completed/ 2002 |
Whey-derived growth factors and treatment of mucositis |
Methodological expertise |
TGR BioSciences Pty Ltd |
|
Dr Anne Donnet-Hughes |
Nestle Inc |
Completed/ 2002 |
Effects of milk growth factors on gut immaturity |
Methodological expertise |
Nestle Inc |
|
Dr Leanna Read |
TGR BioSciences |
Completed/ 2003 |
Milk growth factors and treatment of gastric ulceration |
Methodological expertise |
TGR BioSciences Pty Ltd |
|
Dr Barry Powell |
Child Health Research Institute |
Completed/ 2004 |
Development of a screening assay for intestinal barrier function |
Methodological expertise |
Nestle Inc |
|
Dr Cathy Abbott |
Flinders University |
Completed/ 2006 |
The role of dipeptidyl peptidase IV in inflammatory bowel disease |
Methodological expertise |
Probiodrug Pty Ltd |
|
Dr Phil Giffard |
Queensland University of Technology |
Completed/ 2006 |
Probiotic and prebiotic interactions in gastrointestinal disease |
Methodological expertise |
|
|
Professor Peter Howe |
University of South Australia |
Completed/ 2007 |
Anti-inflammatory lipids and gastrointestinal disease |
Methodological expertise |
Pharmalink Pty Ltd |
|
Mr Chris Booton |
Nidor Pty Ltd |
Completed/ 2008 |
Development of the sucrose breath test of intestinal function |
Methodological expertise |
Nidor Pty Ltd |
|
Dr Marianne Hellers |
BioInnovation SA |
Completed/ 2006 |
In vivo models of GI disease |
Study design |
|
|
Dr Tony Clarkson |
Royal Adelaide Hospital |
Completed/ 1988 |
Aetiology of IgA Nephropathy |
Methodological expertise |
|
|
Dr Kym Bannister |
Royal Adelaide Hospital |
Completed/ 1982 |
Studies on aetiology of Membranous Glomerulonephritis |
Methodological expertise |
|
|
Dr Carlos-George Nascimento |
UCLA Davis, California |
Completed/ 1993 |
Epidermal Growth Factor (EGF) and protection of the intestine |
Methodological expertise |
|
|
Dr Cuong Tran |
Women’s & Children’s Hosp. |
Completed/ 2012 |
Effects of zinc supplementation on gastrointestinal disease |
Methodological expertise |
|
|
Dr Michael Conlon |
CSIRO Division of Human Nutrition |
Completed/ 1995 |
Insulin-like growth factors-I (IGF-I) and –II (IGF-II) and gastrointestinal growth in rats and guinea pigs |
Methodological expertise |
|
|
Dr Rob Fraser |
Dept of Radiation Oncology, Royal Adelaide Hospital |
Completed/ 2000 |
Insulin-like growth factors-I (IGF-I) and radiation enteritis |
Methodological expertise |
|
|
Dr Cory Xian |
Dept of Orthopaedics, Women’s and Children’s Hospital |
Completed/ 2000 |
Role of IGF-I, HGF and trefoil peptides in intestinal mucositis |
Methodological expertise |
|
|
Dr Art Hohmann and Dr Cory Xian |
Child Health Research Institute |
Completed/ 2000 |
Roles of IGF-I, TGFs and co-stimulatory molecules in acute, chronic and pre-neoplastic inflammatory bowel disease |
Methodological expertise
|
|
|
Dr Peter Coyle |
Inst of Medical and Veterinary Science, Adelaide |
Completed/ 2000 |
Role of zinc and metallothionein in intestinal disease |
Methodological expertise |
|
|
A/Prof Ashley Blackshaw |
Nerve-Gut Lab Hanson Institute |
Completed/ 2000 |
Effects of inflammation on bowel innervation |
Methodological expertise |
|
|
Prof Cory Xian |
Sansom Institute, University of South Australia |
Completed/ 2012 |
Chemotherapy-induced mucositis and bone disease |
Study design |
|
|
Dr Aleta Knowles |
Elanco Services (Eli Lilly), Vic; Melbourne |
Completed/ 2006 |
Spinosad and repair of chemotherapy-induced mucositis |
Methodological expertise |
Elanco Services (Eli Lilly), Vic; Melbourne |
|
Dr Claire Roberts |
Dept of Obstetrics and Gynaecology, University of Adelaide |
Completed/ 2005 |
IGF-I and IGF-II: effects on intra-uterine growth retardation in guinea pigs |
Methodological expertise |
|
|
Dr Sharon Byers |
Dept of Chemical Pathology, Women’s and Children’s Hospital, Adelaide |
Current Commenced/ January 2005 |
Effects of new treatments for mucopolysaccharidosis on the gastrointestinal tract |
Methodological expertise |
|
|
Dr Kathy Lee |
Dept of General Medicine, Women’s and Children’s Hospital, Adelaide |
Completed/ |
Hypertonic saline and treatment of bronchiolitis in neonates |
Study design
|
|
|
Mr John Waitzer |
Queensland University |
Completed/ |
Effects of Lyprinol on intestinal mucositis |
Methodological expertise
|
Pharmalink Pty Ltd. Brisbane, Queensland. |
|
Dr Bob Hughes
|
|
Current |
Effects of probiotics and prebiotics on intestinal function in poultry |
Methodological expertise
|
SARDI Poultry CRC |
|
Dr Ric van Tol
|
|
Completed/ |
Effects of new bioactives in a rat model of HIV infection |
Methodological expertise |
Numico Pty Ltd |
|
Mr Chris Gregory
|
|
Current |
Effects of Emu Oil on chemotherapy-induced mucositis |
Methodological expertise |
Emu Tracks |
|
Dr Roger Campbell |
|
Completed/ |
Effects of probiotics and prebiotics on intestinal function in pigs |
Methodological expertise |
SARDI Pork CRC |
|
Dr Luis Borges
|
|
Completed |
Effects of Palifermin on chemotherapy-induced mucositis |
Methodological expertise |
Amgen Inc |
|
Dr Adrian Cummins
|
Queen Elizabeth Hospital |
Current |
Effects of probiotics on intestinal stem-cell expression in chemotherapy-induced mucositis |
Methodological expertise |
|
|
Dr Susan Bastian
|
University of Adelaide (Oenology) |
Current |
Effects of grape seed extract on chemotherapy-induced mucositis and inflammatory bowel disease |
Methodological expertise |
|
|
A/Prof Christine Feinle-Bisset
|
Royal Adelaide Hospital |
Completed/ |
Effects of Iberogast on chemotherapy-induced mucositis and inflammatory bowel disease |
Methodological expertise |
|
|
Dr Luby Simson
|
University of Canberra |
Completed/ |
Effects of mistletoe extract on intestinal disease |
Methodological expertise |
|
|
Prof Andrea Yool
|
University of Adelaide (Physiology) |
Current |
Effects of rhubarb extract on aquaporin channels in inflammatory bowel disease |
Methodological expertise |
|
|
Dr Lindsay Burns
|
Pain Therapeutics |
Completed/ |
Effects of new analgesic agents on inflammatory bowel disease |
Methodological expertise |
|
|
Prof Allison Cowin Dr Zlatko Kopecki |
University of South Australia |
Current |
Effects of new bioactive agents on bowel inflammation in a model of epidermolysis bullosa |
Methodological expertise |
|
|
Dr David Stone
|
SARDI Flinders University |
Current |
Effects of new probiotics and prebiotics on abalone growth |
Methodological expertise |
|
|
Dr Cuong Tran |
CSIRO |
Commenced/ |
Effects of zinc supplementation on gastrointestinal disease |
Methodological expertise |
|
|
Dr Michael Story |
Story Pharmaceuticals |
Commenced/ |
Zinc Monoglycerolate and Emu Oil for treatment of inflammatory bowel diseases |
Methodological expertise |
Emu Tracks Pty Ltd |
|
Dr Roger Yazbek
|
Flinders University |
Commenced/ |
Volatile organic compounds in breath as markers of systemic disease |
Methodological expertise |
|
|
Dr Suzanne Mashtoub |
University of Western Australia |
Commenced/ |
Effects of Emu Oil on inflammatory bowel disease and colon cancer |
Methodological expertise |
|
|
Dr James Munro Prof Mary Barton |
University of South Australia |
Commenced/ |
Bacteriophage treatment of water supplies to prevent infectious diarrhoea |
Methodological expertise |
|
|
Dr Philip Marshall |
ORIL Pty Ltd |
Commenced/2016 |
Testing new anti-colon cancer compounds |
Methodological expertise |
|
Research Experience and Research Goals - Bioactive factors and Gastrointestinal Disease
Utilising in vivo animal model systems, our group was the first to identify insulin-like growth factor-I (IGF-I) as a potent growth factor for the small intestine. Since this discovery, I have been responsible for the development and evolution of animal model systems and novel methodologies that have provided new insights into the mechanisms of growth factor action in vivo . I have been invited to review the role of growth factors in the gastrointestinal tract in the Current Opinion series and Journal of Nutrition. To this end, I have previously investigated the clinical and nutraceutical application of growth factors including epidermal growth factor, IGF-I, IGF-II, transforming growth factor-a, transforming growth factor-b, hepatocyte growth factor, trefoil factors and betacellulin in addition to other agents, such as zinc and whey-derived growth factors. Since 2005 I have broadened my research interests to include mechanistic and pre-clinical studies of naturally-sourced bioactive agents including plant-extracts, marine extracts and probiotics, this culminating in successful grant awards from NHMRC in 2008 and RIRDC in 2009.
I am fully aware of the imperatives for research translation and commercial application of research and have previously utilised model systems of chemotherapy-induced mucositis to test the therapeutic application of a whey-derived growth factor extract. A Phase 1b clinical trial of this extract for treatment of oral mucositis was completed successfully through Melbourne’s Peter MacCallum Cancer Institute in 2002 and Phase IIb studies were completed in February 2008. I am the co-inventor of this treatment and international patents have now been granted. I have used in vivo model systems to test fundamental mechanistic hypotheses relating to the processes of intestinal protection, injury, repair, inflammation and transformation. To date we have developed models of gut immaturity, oral mucositis, gastritis, gastric ulceration, H pylori infection, NSAID-enteropathy, radiation enteritis, chemotherapy-induced mucositis, Crohn’s disease, ulcerative colitis and colonic carcinoma. This repertoire of animal models and associated novel analytical methods, which is available to other researchers, is a valuable resource that is unique in Australia, and possibly, the world. The primary aim of my future research ventures is to further our understanding of nutrition, and the importance of bioactive dietary supplementation in animals and humans, specifically as this relates to diseases and disorders of the gastrointestinal system. I am in the process of expanding my previous research on bioactive factors and the gut to include modulation of the glucagon-like peptide 2 (GLP-2)/dipeptidyl peptidase IV (DPIV) axis in addition to the investigation of probiotics, prebiotics and other naturally-sourced bioactive factors, for the prevention and treatment of gastrointestinal conditions such as intestinal mucositis and inflammatory bowel disease. My current research focuses on the recent development of non-invasive techniques to assess functions of the intestine, including absorption and indicators of intestinal transit, inflammation and ulceration. Although our group has only recently begun investigations into this exciting new research area, we have already been successful in attracting a $500,000 Biotechnology Innovation Fund grant for development of one of the tests (the sucrose breath test - SBT), becoming the first group to describe the SBT and its applicability to intestinal disease.
| Date | Position | Institution name |
|---|---|---|
| 2015 - ongoing | Associate Dean | University of Adelaide |
| 2010 - ongoing | Professor | University of Adelaide |
| 2010 - ongoing | Affiliate Professor | Women's and Children's Hospital |
| 2004 - 2010 | Affiliate Associate Professor | Flinders University |
| 2003 - ongoing | Affiliate Senior Scientist | University of South Australia |
| 2003 - 2009 | Adjunct Professor | University of South Australia |
| 2002 - 2010 | Affiliate Associate Professor | Women's and Children's Hospital |
| 2001 - ongoing | Visiting Research Fellow | University of Adelaide |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2001 - 2002 | University of Adelaide | Australia | PhD |
| 1976 - 1976 | University of Adelaide | Australia | B Sc (Hons) |
| 1973 - 1975 | University of Adelaide | Australia | B Sc |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2006 | Fellow | American Gastroenterological Association | United States |
| 2004 | Associate Member | Royal College of Pathologists of Australasia | Australia |
| Year | Citation |
|---|---|
| 2024 | Mashtoub, S., Mhlanga, S., Barreto, S. G., Hammond, P., & Howarth, G. (2024). Use of high-resolution colonoscopy to accurately monitor disease progression in a murine model of colitis-associated colorectal cancer. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 39 (pp. 43). WILEY. |
| 2024 | Thomson, S., Kennewell, T., Howarth, G., & Mashtoub, S. (2024). Distal colonic crypt hyperplasia is not adversely impacted by emu oil and saireito in a murine model of colitis-associated colorectal cancer. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 39 (pp. 42). WILEY. |
| 2024 | Mhlanga, S. N., Howarth, G. S., Maiolo, K. E., Chartier, L. C., Trinder, D., Lawrance, I. C., . . . Mashtoub, S. (2024). Orally-Administered Emu Oil Reduces Proximal Colonic Crypt Hyperplasia in a Murine Model of Colitis-Associated Colorectal Cancer (vol 8, 102567, 2024). In CURRENT DEVELOPMENTS IN NUTRITION Vol. 8 (pp. 1 page). ELSEVIER SCIENCE INC. |
| 2024 | Mhlanga, S. N., Howarth, G. S., Ndukwe, S., Wanner, K. E., Mitchell, C. J., Chartier, L. C., & Mashtoub, S. (2024). Emu Oil-Modulated Faecal Microbiota Transplantation Improves Disease Indicators in a Mouse Model of Crohn's-Like Colitis (vol 8, 103476, 2024). In CURRENT DEVELOPMENTS IN NUTRITION Vol. 8 (pp. 1 page). ELSEVIER SCIENCE INC. |
| 2023 | Kennewell, T., Mhlanga, S., Howarth, G., Chartier, L., Fujino, J., Mitchell, C., . . . Mashtoub, S. (2023). Kampo medicine (orengedokuto) improves stool consistency in a mouse model of 5-fluorouracil-induced mucositis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 200). WILEY. |
| 2023 | Mashtoub, S., Maiolo, K., Chartier, L., Trinder, D., Lawrence, I., Barker, S., . . . Howarth, G. (2023). Emu oil reduces proximal colonic crypt hyperplasia in a murine model of colitis-associated colorectal cancer. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 106). WILEY. |
| 2022 | Ndukwe, S., Wanner, K., Mitchell, C., Chartier, L., Howarth, G., & Mashtoub, S. (2022). Emu oil-modulated fecal microbiota transplantation reduces histologically assessed disease severity in a mouse model of Crohn's-like colitis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 105-106). WILEY. |
| 2019 | Jatmiko, Y. D., Howarth, G. S., & Barton, M. D. (2019). Evaluation of Yeast Diversity in Dadih and Dangke Using PCR-RFLP of Internal Transcribed Spacer Region. In IOP Conference Series: Earth and Environmental Science Vol. 391 (pp. 1-11). online: IOP Publishing. DOI Scopus8 |
| 2018 | Jatmiko, Y., Howarth, G., & Barton, M. (2018). Naturally fermented milk and its therapeutic potential in the treatment of inflammatory intestinal disorders. In AIP Conference Proceedings Vol. 2019 (pp. 060009-1-060009-16). Indonesia: AIP. DOI Scopus9 WoS7 |
| 2018 | Chartier, L. C., Maiolo, K. E., Howarth, G. S., Lawrance, I., Trinder, D., Barker, S. J., . . . Mashtoub, S. (2018). EMU OIL IMPROVES CLINICAL INDICATORS OF DISEASE AND REDUCES PROXIMAL COLONIC CRYPT HYPERPLASIA IN A MURINE MODEL OF COLITIS-ASSOCIATED COLORECTAL CANCER. In GASTROENTEROLOGY Vol. 154 (pp. S875). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. WoS2 |
| 2017 | Barker, T. H., George, R. P., Howarth, G. S., & Whittaker, A. L. (2017). The Assessment of Housing Density and Social Hierarchy of Laboratory Rats on Behavioural Measures to Assess Welfare. In 2017 Australian & New Zealand Council for the Care of Animals in Research and Teaching Conference, ‘Maintaining Social License in a Changing World’. Queenstown, New Zealand. |
| 2017 | Jatmiko, Y., Howarth, G., & Barton, M. (2017). Assessment of probiotic properties of lactic acid bacteria isolated from Indonesian naturally fermented milk. In C. Salunkhe, A. Kikuchi, B. Govinda, Y. Jatmiko, & D. Siswanto (Eds.), AIP Conference Proceedings Vol. 1908 (pp. 050008-1-050008-14). US: AIP. DOI Scopus19 WoS13 |
| 2016 | Barker, T. H., Howarth, G. S., & Whittaker, A. L. (2016). Judgement Biases: Metabolic cage housing and sex effects. In Applied Animal Behaviour Science. Adelaide, South Australia: Elsevier BV. |
| 2016 | Bajic, J., Whittaker, A., Bobrovskaya, L., Hutchinson, M., & Howarth, G. (2016). Intestinal mucositis induced by 5-Fluorouracil results in glial changes modified by analgesics via neuro-immune mechanisms. In Australian Society for Medical Research. Adelaide. |
| 2014 | Cheah, K. Y., Howarth, G. S., Bindon, K. A., Kennedy, J. A., Mashtoub, S., & Bastian, S. E. (2014). Low Molecular Weight Procyanidins From Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Colon Cancer Cells. In GASTROENTEROLOGY Vol. 146 (pp. S341). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. WoS1 |
| 2011 | Woenig, J. A., Gower, P. K., Howarth, G. S., Roberts-Thomson, I. C., & Cummins, A. G. (2011). Inhibition of Notch Signalling Decreases Crypt Fission but Increases Apoptosis of Crypt Cells in the Small Intestine of the Infant Rat. In GASTROENTEROLOGY Vol. 140 (pp. S472). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2010 | Yazbeck, R., Howarth, G. S., Butler, R. N., Geier, M. S., & Abbott, C. A. (2010). Dipeptidyl Peptidase-IV Inhibitors and Small Intestinal Adaptation During Experimental Colitis. In GASTROENTEROLOGY Vol. 138 (pp. S429). W B SAUNDERS CO-ELSEVIER INC. |
| 2009 | Xian, C. J., Fan, C. M., Cool, J. C., Scherer, M. A., King, T., Georgiou, K., . . . Foster, B. K. (2009). Pathophysiology and prevention of cancer chemotherapy-induced bone growth defects. In BONE Vol. 45 (pp. S103). Cambridge, ENGLAND: ELSEVIER SCIENCE INC. DOI |
| 2009 | Prisciandaro, L., Geier, M., Butler, R., Cummins, A., & Howarth, G. (2009). Compounds secreted from Escherichia Coli Nissle 1917, Streptococcus Thermophilus Th-4 and Lactobacillus Fermentum Br11 maintain intestinal cell viability following 5-fluorouracil administration in vitro. In Abstracts of the 2009 International MASCC/ISOO Syposium Vol. 17 (pp. 913-914). Italy: Springer. DOI |
| 2009 | Cheah, K., Bastian, S., Acott, T., & Howarth, G. (2009). Grape seed extract: effects on chemotherapy-induced mucositis and inflammatory bowel disease in rats. In Proceedings of the 2009 International MASCC/ISOO Syposium (pp. 905-906). Italy: Springer. DOI |
| 2009 | Prisciandaro, L., Geier, M., Butler, R., Cummins, A., & Howarth, G. (2009). Factors secreted from Lactobacillus fermentum Br11 and Escherichia Coli Nissle 1917 as a potential therapy for 5-fluorouracil induced mucositis: a pilot study. In Abstracts of the 2009 International MASCC/ISOO Symposium (pp. 913-914). Italy: Springer. DOI |
| 2009 | Mashtoub, S., Lindsay, R., Lymn, K., Geier, M., Butler, R., & Howarth, G. (2009). Emu oil improves parameters of intestinal integrity in rat models of inflammatory bowel disease and intestinal mucositis. In Abstracts of the 2009 International MASCC/ISOO Symposium (pp. 910-911). Italy: Springer. DOI |
| 2009 | Tran, C., Sundar, S., Howarth, G., & Butler, R. (2009). Use of the 13C-sucrose breath test to assess small bowel integrity in methotrexate-induced mucositis following zinc supplementation in metallothionein-knockout and wild-type mice. In Journal of Gastroenterology and Hepatology (pp. 328). Australia: Wiley-Blackwell. DOI |
| 2009 | Fauser, J., Butler, R., Cummins, A., Matthews, G., & Howarth, G. (2009). Modulation of the intracellular redox state induces apoptosis in the Caco-2 cell line. In Journal of Gastroenterology and Hepatology Vol. 24 (pp. 0 pages). Australia: Wiley-Blackwell. DOI |
| 2009 | Prisciandaro, L., Geier, M., Butler, R., Cummins, A., Howarth, G., & Abbott, C. (2009). Probiotic factors protect intestinal cells from chemotherapy-induced cytotoxicity and improve parameters of 5-fluorouracil induced intestinal mucositis in rats. In Journal of Gastroenterology and Hepatology Vol. 24 (pp. 328). Australia: Wiley-Blackwell. DOI |
| 2007 | Price, T. J., Morelli, L., Howarth, G. S., Webster, J., Zacharakis, B., Brooker, C., . . . Butler, R. N. (2007). Residual damage to the small intestine induced by chemotherapy can be detected and monitored using the non-invasive <SUP>13</SUP>C Sucrose Breath Test (SBT). In EJC SUPPLEMENTS Vol. 5 (pp. 152). Barcelona, SPAIN: PERGAMON-ELSEVIER SCIENCE LTD. DOI |
| 2007 | Torres, D. M., Butler, R. N., & Howarth, G. S. (2007). Lyprinol™ partially ameliorates 5-fluorouracil (5-FU)-induced mucositis in the rat. In GASTROENTEROLOGY Vol. 132 (pp. A570-A571). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2007 | Yazbeck, R., Howarth, G. S., Demuth, H. U., Holst, J. J., & Abbott, C. A. (2007). Inhibition of dipeptidyl peptidase activity increases circulating glucagon-like peptide-2 and decreases neutrophil infiltration during experimental colitis in mice. In GASTROENTEROLOGY Vol. 132 (pp. A369-A370). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. WoS2 |
| 2007 | Forder, R., Howarth, G. S., Tivey, D. R., & Hughes, R. J. (2007). Changes in ileal mucin composition through interactions with intestinal microflora during early post-hatch development of poultry. In GASTROENTEROLOGY Vol. 132 (pp. A551). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2007 | Smith, C. L., Geier, M. S., Butler, R. N., & Howarth, G. S. (2007). Dextran sulfate sodium-induced Crypt hyperplasia in the jejunum and ileum is prevented by oral administration of <i>Lactobacillus Fermentum</i> Br11 and <i>Bifidobacterium Lactis</i> Bb12 to rats. In GASTROENTEROLOGY Vol. 132 (pp. A370). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2007 | Smith, C. L., Butler, R. N., & Howarth, G. S. (2007). <i>Lactobacillus fermentum</i> Br11 and fructo-oligosaccharide partially reduce jejunal inflammation but not overall damage severity of 5-fluoro-uracil-induced mucositis in rats. In GASTROENTEROLOGY Vol. 132 (pp. A714). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2007 | Tran, C. D., Ball, J., Sundar, S., & Howarth, G. S. (2007). The role of zinc (Zn) and metallothionein (MT) in dextran sulfate sodium (DSS)-induced colitis in MT-null (MT-/-) and wild-type mice. In FASEB JOURNAL Vol. 21 (pp. A1120). Washington, DC: FEDERATION AMER SOC EXP BIOL. WoS1 |
| 2006 | Yazbeck, R., Sulda, M. L., Howarth, G. S., & Abbott, C. A. (2006). Dipeptidyl peptidases and their expression in a murine model of experimental. In GASTROENTEROLOGY Vol. 130 (pp. A347). Los Angeles, CA: W B SAUNDERS CO-ELSEVIER INC. |
| 2006 | Yazbeck, R., Abbott, C. A., Howarth, G. S., & Demuth, H. -U. (2006). Inhibition of dipeptidyl peptidase activity in DPIV knock-out mice and wild type mice decreases disease activity in experimental colitis. In GASTROENTEROLOGY Vol. 130 (pp. A345). Los Angeles, CA: W B SAUNDERS CO-ELSEVIER INC. |
| 2006 | Howarth, G. (2006). Probiotics and inflammatory bowel disease. In Emerging issues in inflammatory bowel diseases: proceedings of the Falk Symposium 151 held in Sydney, Australia, March 24-25, 2006 Vol. 151 (pp. 281-295). Sydney, NSW, Australia: Springer. |
| 2005 | Kamil, R., Butler, R., Geier, M. S., & Howarth, G. (2005). <i>Lactobacillus GG</i> but not Bifidobacterium BB12 increases severity of Indomathacin-induced intestinal ulceration in rats. In GASTROENTEROLOGY Vol. 128 (pp. A604). Chicago, IL: W B SAUNDERS CO. WoS2 |
| 2005 | Geier, M. S., Butler, R. N., & Howarth, G. S. (2005). Differential efficacy of probiotic species in amelioration of dextran sulphate sodium-induced colitis in rats. In GASTROENTEROLOGY Vol. 128 (pp. A603-A604). Chicago, IL: W B SAUNDERS CO. WoS3 |
| 2005 | Howarth, G. S., Inglis, K. L., Davidson, G. P., & Butler, R. N. (2005). The Sucrose Breath Test (sbt): a simple, rapid, non-invasive method to assess intestinal mucositis induced by different classes of chemotherapy drugs.. In GASTROENTEROLOGY Vol. 128 (pp. A552). Chicago, IL: W B SAUNDERS CO. |
| 2005 | Yazbek, R., Demuth, H. U., Geier, M. S., Abbott, C. A., & Howarth, G. S. (2005). Inhibition of dipeptidyl peptidase IV-like activity partially ameliorates development of experimentally-induced colitis in mice. In GASTROENTEROLOGY Vol. 128 (pp. A200). Chicago, IL: W B SAUNDERS CO. |
| 2004 | Geier, M., Abbott, C., Tenikoff, D., McCaughan, G., & Howarth, G. (2004). Development and resolution of experimental colitis in dipeptidyl peptidase IV knockout mice. In GASTROENTEROLOGY Vol. 126 (pp. A142). New Orleans, LA: W B SAUNDERS CO. |
| 2004 | Coldwell, J. R., Howarth, G. L., & Blackshaw, L. A. (2004). Colonic extraluminal mechanoreceptors and inflammation in the rat colon. In GASTROENTEROLOGY Vol. 126 (pp. A164). New Orleans, LA: W B SAUNDERS CO. |
| 2004 | Coldwell, J. R., Howarth, G. L., & Blackshaw, A. (2004). High threshold rat colonic afferents directly respond to mast cell degranulation in acute inflammation. In GASTROENTEROLOGY Vol. 126 (pp. A161). New Orleans, LA: W B SAUNDERS CO. |
| 2004 | Coldwell, J. R., Howarth, G. L., & Blackshaw, L. A. (2004). Increased colonic afferent sensitivity to 5-HT in inflammation and recovery. In GASTROENTEROLOGY Vol. 126 (pp. A94). New Orleans, LA: W B SAUNDERS CO. |
| 2003 | Dyer, J. L., Butler, R. N., Xian, C. J., & Howarth, G. S. (2003). Partial attenuation of 5-fluorouracil (5-FU)-induced intestinal mucositis by pretreatment with insulin-like growth factor-I (IGF-I) in rats. In GASTROENTEROLOGY Vol. 124 (pp. A597). ORLANDO, FLORIDA: W B SAUNDERS CO. DOI |
| 2003 | Cool, J. C., Seymour-Griffin, C. L., Geier, M. S., Tenikoff, D., Lee, S. S., Dang, Y. P., . . . Howarth, G. S. (2003). Temporal profile of repair and proliferation during recovery from indomethacin injury in the rat stomach. In GASTROENTEROLOGY Vol. 124 (pp. A174). ORLANDO, FLORIDA: W B SAUNDERS CO. |
| 1999 | Tran, C. P., Familari, M., Whitehead, R. H., & Giraud, A. S. (1999). Characterisation of a butyrate response element in the human trefoil factor 3 gene promoter. In GASTROENTEROLOGY Vol. 116 (pp. A940). W B SAUNDERS CO-ELSEVIER INC. |
| 1998 | Steeb, C. B., Shoubridge, C. A., Lamb, J., Howarth, G. S., & Read, L. C. (1998). Role of insulin-like growth factor-I in gastrointestinal growth and repair. In K. Takano, N. Hizuka, & S. I. Takahashi (Eds.), MOLECULAR MECHANISMS TO REGULATE THE ACTIVITIES OF INSULIN-LIKE GROWTH FACTORS Vol. 1151 (pp. 331-339). TOKYO, JAPAN: ELSEVIER SCIENCE BV. |
| 1997 | Xian, C. J., Mardell, C. E., & Read, L. C. (1997). Differential changes in immunoreactivity of TGF alpha and beta 1 in colonic mucosa in childhood inflammatory bowel disease. In GASTROENTEROLOGY Vol. 112 (pp. A1122). W B SAUNDERS CO-ELSEVIER INC. |
| 1994 | READ, L. C., HOWARTH, G. S., STEEB, C. B., & LEMMEY, A. B. (1994). IN-VIVO EFFECTS OF IGF-I ON GUT GROWTH AND FUNCTION. In R. C. Baxter, P. D. Gluckman, & R. G. Rosenfeld (Eds.), INSULIN-LIKE GROWTH FACTORS AND THEIR REGULATORY PROTEINS Vol. 1056 (pp. 409-416). SYDNEY, AUSTRALIA: ELSEVIER SCIENCE PUBL B V. WoS1 |
| 1992 | READ, L. C., HOWARTH, G. S., LEMMEY, A. B., STEEB, C., TRAHAIR, J., TOMAS, F. M., & BALLARD, F. J. (1992). THE GASTROINTESTINAL-TRACT - A MOST SENSITIVE TARGET FOR IGF-I. In G. P. Savage (Ed.), PROCEEDINGS OF THE NUTRITION SOCIETY OF NEW ZEALAND, VOL 17 Vol. 17 (pp. 38-44). MASSEY UNIV, PALMERSTON NORTH, NEW ZEALAND: NUTRITION SOC NEW ZEALAND. |
Currently held Competitive Grants
| Title | Funding Body | Investigators | Years | Funds |
|---|---|---|---|---|
| New inhibitors of colon cancer development |
Oncology Research International |
G Howarth |
2016-2017 |
$126,000 |
| Biomarker development to monitor disease progression in Huntington’s transgenic sheep | Brain Research New Zealand | G Howarth R Snell |
2016-2017 | $219,980 |
Currently held Industry Grants
| Title | Funding Body | Investigators | Years | Funds |
|---|---|---|---|---|
| ZMG-Emu Oil and experimental colitis | Story Pharmaceuticals |
G Howarth |
2015 | $37,714 |
Past Support
| Title | Funding Body | Investigators | Years | Funds |
|---|---|---|---|---|
| Insulin-like growth factors and treatment of gastric ulceration disease | CRC for Tissue Growth and Repair |
G Howarth |
1997-2002 | $700,000 |
| Milk growth factors and treatment of experimental inflammatory bowel disease | Nutricia Inc |
G Howarth |
1997-1999 | $320,000 |
| Whey growth factors and prevention of oral mucositis | R&D Syndicate |
L Read |
1995-1998 | $3.4 mill |
| Milk-derived growth factors and treatment of intestinal mucositis | Mead-Johnson Inc Cephalon Inc |
L Read |
1993-1994 | $50,000 |
| Effects of IGF-I on DSS-induced colonic carcinoma in rats | Anti-Cancer Foundation of South Australia |
G Howarth |
1995-1996 | $17,000 |
| IGF-I effects on IBD-induced colon cancer |
Crohn’s and Colitis Association of South Australia Equipment Grant |
G Howarth |
1996 | $4,500 |
| Whey growth factors and treatment of oral mucositis | Channel 7 Children's Medical Research Foundation of South Australia |
G Howarth |
1995-1996 | $20,000 |
| Milk-derived growth factors and treatment of gastritis | CRC for Tissue Growth and Repair |
L Read |
1998-2003 | $700,000 |
| Whey growth factor effects on ulcerative colitis |
Crohn’s and Colitis Association of South Australia (Equipment grant), |
G Howarth |
1999 | $2,500 |
| Milk-derived growth factor formulations for treatment of gut immaturity and ulceration | Nestle Inc |
L Read |
2000-2002 | $800,000 |
| Milk-derived growth factor formulations for treatment of gastric ulceration | Biotechnology Innovation Fund |
L Read |
2001-2003 | $500,000 |
| The potential role of DPIV in inflammatory bowel disease | Channel 7 Children's Medical Research Foundation of South Australia |
G Howarth |
2003-2004 | $35,000 |
| Development of a novel non-invasive test to monitor intestinal function | Biotechnology Innovation Fund |
R Butler |
2003-2005 | $498,000 |
| Inhibitors of DPIV and treatment of inflammatory bowel disease | Channel 7 Children's Medical Research Foundation of South Australia |
G Howarth |
2004-2005 | $55,000 |
| Folate-producing probiotics and amelioration of intestinal mucositis | Cancer Council SA |
G Howarth |
2005-2006 | $50,000 |
| Research Fellowship | Cancer Council SA |
G Howarth |
2005-2008 | $250,000 |
|
Refurbishment of Small Animal House and installation of Metabolism caging |
University of Adelaide |
G Howarth |
2006 | $70,000 |
| Spinosad and repair of chemotherapy-induced mucositis | Elanco Animal Services (Eli Lilly) |
G Howarth |
2006 | $20,000 |
| New bioactive factors for treatment of HIV | Numico Pty Ltd |
R Butler |
2006-2007 | $120,000 |
|
Effects of increasing dietary fat content on carcass composition in pigs |
Pork CRC |
R Campbell |
2006 2007 2008 |
$20,000 $20,000 $20,000 |
| Palifermin (KGF) and repair of chemotherapy-induced mucositis | Amgen Pty Ltd |
G Howarth |
2006-2008 | $80,000 |
|
Clinical trial of Lactermin for treatment of chemotherapy-induced mucositis |
Commercial Ready |
*Awarded to TGR BioSciences |
2006-2008 | *$1,300,000 |
| Emu Oil : role in chemotherapy-induced mucositis and IBD | Emu Tracks |
G Howarth |
2007-2008 | $30,000 |
|
The extent of competition between the native and introduced herbivores of Kangaroo Island |
ARC |
P Stott |
2007 |
$35,000 |
|
Novel probiotics and naturally- sourced extracts as a treatment strategy for chemotherapy-induced intestinal mucositis |
Cancer Council SA |
G Howarth |
2008 | $82,750 |
| Probiotic effects on chronic colonic inflammation and DNA methylation status during tumourigenesis | Cancer Council SA |
G Howarth |
2008 | $82,750 |
| Evaluation of a novel nutraceutical from muricid molluscs as complementary medicine for gastrointestinal diseases | Bushell Foundation |
K Benkendorff |
2008 2009 |
$108,100 $105,000 |
| Development of a new treatment for canine mucositis |
Nidor Pty Ltd/ BioIberica Inc |
G Howarth C Booton |
2009-2010 | $80,000 |
| Novel probiotics and naturally-sourced extracts in chemotherapy-induced mucositis | Sally Birch Cancer Council Senior Research Fellowship in Cancer Control |
G Howarth |
2009 |
$100,000 |
| Novel probiotics and naturally-sourced extracts in chemotherapy-induced mucositis | NHMRC Complementary Medicine |
G Howarth |
2008 |
$121,750 |
| Emu Oil treatments for gastrointestinal disease | Rural Industries Research and Development Corporation | G Howarth |
2010 |
$120,000 |
| Filamin A binding compounds and protection from intestinal disease | Pain Therapeutics Pty Ltd | G Howarth | 2012 | $30,000 |
| Night camera video imaging for animal model behaviour studies | Faculty of Sciences |
G Howarth P Stott |
2013 | $8,700 |
| Novel nutraceutical formulations for alleviation of chemotherapy-induced intestinal mucositis | SA Cancer Research Collaborative Fellowship | G Howarth |
2012 |
$105,000 |
Teaching Interests
Professor Howarth is the coordinator for the Laboratory Animal Science course that was introduced in the B Sc (Animal Science) program in 2007. Professor Howarth is a work experience student coordinator at the University and at the Women's and Children's Hospital. He also supervises groups of 3rd year Physiology students and DVM-1 students in research projects annually. Professor Howarth currently supervises 9 PhD students and two Honours students in his laboratory.
Postgraduate and Undergraduate Teaching
In addition to his position at the University of Adelaide, Professor Howarth has been appointed to affiliate academic positions in the other South Australian universities: the University of South Australia and Flinders University. These affiliations have considerably expanded his ability to attract quality students to his research group. Professor Howarth has also been actively involved in giving presentations to tertiary student bodies such as the Wilto Yerlo Centre for Australian Indigenous Research & Studies (2006).
Undergraduate Teaching
- Completed the University of Adelaide (Centre for Professional Learning and Certificate course: “Teaching at University (TaU)” [2005] Invited to present my work in the TaU course at the ‘Investigations into University Learning and Teaching’ Tri-institutional Symposium held in Adelaide (February 2006)
- Completed the introductory MyUni course at the University of Adelaide [2005]
- Participant in the ‘Twinning’ Program bridging Scientists with School Science Teachers [2004-Present].
- Commenced undergraduate lecturing at University of Adelaide (Roseworthy campus) [Animal Biotechnology] in February 2006.
- First student evaluation of teaching conducted in June 2008. Student Evaluation of Learning and Teaching (SELT) analysis resulted in the following scores (median responses) for the 3rd year Laboratory Animal Science course (91% responses).
- Evaluation rated from 1 (unsatisfactory) to 7 (outstanding)
- Effectiveness as a University teacher: SELT score = 6
- Organization of the teacher: SELT score = 6
- Concern for students: SELT score = 6
- Demonstrates enthusiasm for encouraging student learning: SELT score = 6
- Teacher encourages student participation: SELT score = 6
- Teacher stimulates my interest in learning in this course: SELT score = 5
- Teacher gives clear explanations: SELT score = 6
- eSELT score: Effectiveness as a teacher = 6 (2015)
- 2006-2008, Nutrition and Metabolism [3rd year BSc (An Sci)] Course Coordinator together with Ms Sarah Pain– Semester II
- 2007-Present, Laboratory Animal Science [3rd year BSc (An Sci)] Course Coordinator with Dr Sarah Pain (2007 and 2008); Dr Roger Yazbek (2009 and 2010); Dr Alexandra Whittaker (2011 to 2015)
Undergraduate Research Students
- 1999- Present, University of Adelaide, Discipline of Physiology (3rd year research Project students: 4 students/year)
- 2001- 2007, University of SA, School of Pharmaceutical and Biomedical Sciences (4th year Biotechnology students: 1-2 students for 3-months each year)
- 2000- Present, University of Adelaide, Faculty of Health Sciences (4th year research Project students: occasional student)
- 2000- Present, Flinders University, School of Biological Sciences (final year research projects occasional student)
- 2005, Ms Hanh Lam (Final-year student) Co-supervisor. Health Sciences, University of South Australia
- 2005, Ms Alvina Lim (Final-year student) Co-supervisor. Health Sciences, University of South Australia
- 2005, Ms Lisa Nicholas, Ms Lisa Philp, Ms Nivanee Nair, Ms Jane Chapman, Ms Kelly Roberts and Ms Cassie Smith. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2006, Ms Kim Maiolo, Ms Eugenie Lim, Ms Kris Hyang, Ms Grace Chan, Ms Shervi Lie, Ms Flavia Lee. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2007, Ms Miranda Leach, Ms Annika Wendland, Ms Rachel Jennings, Ms Suzanne Mashtoub. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2008, Ms Xiao Dan Ding, Ms Megan Vu, Ms Masooma Sultani, Mr Bang Hoang. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2009, Mr James Milosh, Ms Jessica Ryan, Ms Ellen Musolino. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2010, Ms Ella Bourne, Ms Kristen Brown, Ms Christine Nguyen, Mr James Selby. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2011, Ms Jessica Panini, Ms Zahra Lotfollahi, Mr Damiano Stomaci, Mr Liam Hoyle, Ms Elaine Penascoza. 3rd Year Physiology Research Project students. Co-supervisor (with PhD student, Ms Suzanne Abimosleh). Dept of Physiology, University of Adelaide
- 2012, Ms Juliana Bajic, Ms Elaine Penascoza. 3rd Year Physiology Project students. Co-supervisor (with PhD student, Ms Suzanne Abimosleh). Dept of Physiology, University of Adelaide
- 2013, Mr Karl Ramsden, Ms Imogen Abernethy, Ms Erica Freitas Lima Lemos. 3rd Year Physiology Research Project students. Co-supervisor (with post-doc, Dr Roger Yazbek). Dept of Physiology, University of Adelaide
- 2014, Ms Dania Ruminski-Smith, Ms Lauren Chartier, Mr Scott Barker, Ms Hana Seo, Ms Romina Ghaemi, Ms Jacinta Fong. 3rd Year Physiology Research Project students. Co-supervisor (with post-doc, Dr Suzanne Mashtoub). Dept of Physiology, University of Western Australia
- 2015, Ms Jacqueline Edwards, Ms Rosa Harmer, Ms Yunsi Lei, Ms Samantha Perera. Ms Jessica Flavel. 3rd Year Physiology Research Project students. Co-supervisor (with post-doc, Dr Suzanne Mashtoub). Dept of Physiology, University of Western Australia
Vacation Scholarship Students (6-8 week summer placements)
- 1998, Ms Fiona Clark (School of Biological Sciences, Flinders University)
- 1999, Ms Olgatina Bucco (Discipline of Physiology, University of Adelaide)
- 2001, Mr Adrian Liston (Discipline of Physiology, University of Adelaide)
- 2002, Ms Katy Ramsden (Discipline of Physiology, University of Adelaide)
- 2003, Ms Rasha Kamil (Discipline of Physiology, University of Adelaide)
- 2005, Ms Swagatha Sundar (School of Pharmacy and Medical Science, University of South Australia)
- 2005, Mr Simon Moretta (School of Pharmacy and Medical Science, University of South Australia)
- 2006, Ms Lauren Savage (School of Agriculture, Food and Wine, University of Adelaide)
- 2006, Ms Amanda McLean (School of Agriculture, Food and Wine, University of Adelaide)
- 2009, Ms Caitlin Brook (School of Animal and Veterinary Sciences, University of Adelaide)
- 2010, Ms Andrea Fernandez (School of Medical Sciences, University of Adelaide)
- 2011, Ms Zahra Lotfollahi (School of Medical Sciences, University of Adelaide)
- 2012, Mr Brett Lange (School of Animal and Veterinary Sciences, University of Adelaide)
- 2014, Ms Farrah Preston (School of Animal and Veterinary Sciences, University of Adelaide)
- 2015, Ms Amy Bates and Ms Georgia Wallace (School of Animal and Veterinary Sciences, University of Adelaide)
International Research Students (6-8 week placements)
- 2010, Mr Loic Antoine (Ecole Nationale Veterinaire, Toulouse, France)
- 2010, Mr Baptiste Pouchan (Ecole Nationale Veterinaire, Toulouse, France)
Previous Postgraduate Student Training (with resulting peer-reviewed publications)
- 1983, Dr Jane Lomax-Smith (FRCPA and PhD, with Dr Andrew Woodroffe)
- 1983, Dr Amanda Gramp (FRCPA, with Professor Barrie Vernon-Roberts)
- 1984, Dr Kym Bannister (MD, with Dr Andrew Woodroffe)
- 1993, Ms Karen Ribbons (PhD, with Dr Leanna Read)
- 1994, Mr Andrew Lemmey (PhD, with Dr Leanna Read)
- 1995, Mr Michael Conlon (PhD, with Dr Frank Tomas)
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2024 | Co-Supervisor | Clinical trial of orally-administered Emu Oil in children with ulcerative colitis. | Doctor of Philosophy | Doctorate | Full Time | Ms Sisanda Nomcebo Mhlanga |
| 2024 | Principal Supervisor | Investigation of acute phase proteins in endangered South-east Asian animals | Doctor of Philosophy | Doctorate | Full Time | Dr Shin Min Chong |
| 2024 | Co-Supervisor | Clinical trial of orally-administered Emu Oil in children with ulcerative colitis. | Doctor of Philosophy | Doctorate | Full Time | Ms Sisanda Nomcebo Mhlanga |
| 2024 | Principal Supervisor | Investigation of acute phase proteins in endangered South-east Asian animals | Doctor of Philosophy | Doctorate | Full Time | Dr Shin Min Chong |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2017 - 2021 | Principal Supervisor | Emu Oil in Combination with Herbal Preparations Provides a Novel Adjunctive Approach to Colitis-Associated Colorectal Cancer Prevention | Doctor of Philosophy | Doctorate | Full Time | Miss Lauren Claire Chartier |
| 2016 - 2021 | Principal Supervisor | An Investigation into Neuroimmune, Cognitive and Affective Behaviour after Chemotherapy Exposure in a Rat Model: Implications for Chemotherapy-induced Gut Toxicity and 'Chemobrain' | Doctor of Philosophy | Doctorate | Full Time | Dr Rebecca Peta George |
| 2016 - 2022 | Co-Supervisor | PROMOTION OF CRYPT FISSION BY THE WNT-b-CATENIN SIGNALLING PATHWAY IN HUMANS AND RATS | Doctor of Philosophy | Doctorate | Full Time | Mrs Zenab Mustansir Dudhwala |
| 2015 - 2018 | Principal Supervisor | Analysis of the Judgement Bias Test for Welfare Assessment in Rats | Doctor of Philosophy | Doctorate | Full Time | Mr Timothy Hugh Barker |
| 2015 - 2022 | Principal Supervisor | Thermoregulation in exercising horses: Aspects of temperature monitoring during field exercise | Doctor of Philosophy under a Jointly-awarded Degree Agreement with | Doctorate | Part Time | Dr Lidwien Verdegaal |
| 2015 - 2018 | Co-Supervisor | Antimicrobial resistance in companion animal pathogens in Australia and assessment of pradofloxacin on the gut microbiota | Doctor of Philosophy | Doctorate | Full Time | Mr Sugiyono Saputra |
| 2014 - 2017 | Principal Supervisor | Biomarkers of Increased Intestinal Permeability in Chickens | Doctor of Philosophy | Doctorate | Full Time | Mr Saad Gilani |
| 2014 - 2019 | Co-Supervisor | From the Bottom Up: Chemotherapy-Induced Gut Toxicity, Glial Reactivity and Cognitive Impairment | Doctor of Philosophy | Doctorate | Part Time | Dr Juliana Esma Bajic |
| 2012 - 2016 | Principal Supervisor | Probiotic-Derived Factors as Potential Chemopreventive Agents for Intestinal Mucositis and Colon Cancer | Doctor of Philosophy | Doctorate | Full Time | Miss Hanru Wang |
| 2012 - 2017 | Principal Supervisor | Naturally-Fermented Milk from Indonesia: A Study of Microbial Diversity and Probiotic Potency for the Potential Treatment of Intestinal Mucositis | Doctor of Philosophy | Doctorate | Full Time | Mr Yoga Dwi Jatmiko |
| 2011 - 2012 | Co-Supervisor | A Test of the Hutchinson Theory of Interspecific Competition | Doctor of Philosophy | Doctorate | Full Time | Mr Richard Bosworth |
| 2011 - 2016 | Principal Supervisor | Evaluation of Indices of Affective State in a Rat Model of Chemotherapy-induced Mucositis | Doctor of Philosophy | Doctorate | Part Time | APrf Alexandra Whittaker |
| 2010 - 2013 | Principal Supervisor | Emu Oil Promotes Intestinal Repair in Rat Models of Enteric Inflammation | Doctor of Philosophy | Doctorate | Full Time | Dr Suzanne Mashtoub |
| 2008 - 2016 | Principal Supervisor | Heat Stress in Racing Greyhounds | Doctor of Philosophy | Doctorate | Part Time | Ms Jane McNicholl |
| 2008 - 2012 | Co-Supervisor | Grape Sourced Bioactives: A Potential New Treatment Strategy for Intestinal Mucositis and Colon Cancer | Doctor of Philosophy | Doctorate | Full Time | Miss Ker Yeaw Cheah |
| 2008 - 2013 | Principal Supervisor | Probiotic-Derived Factors for the Treatment and Prevention of 5-Fluorouracil-Induced Intestinal Mucositis | Doctor of Philosophy | Doctorate | Full Time | Mr Luca Prisciandaro |
| 2006 - 2007 | Principal Supervisor | An in vivo Model to Study Mucin-bacterial Interactions During Early Post-hatch Development of Broiler Chickens | Doctor of Philosophy | Doctorate | Full Time | Dr Bec Forder |
| 2006 - 2013 | Principal Supervisor | Medium Chain Fatty Acids and Wnt/B-Catenin Inhibitors as Adjunctive Colorectal Cancer Chemotherapeutic Agents | Doctor of Philosophy | Doctorate | Full Time | Ms Jane Fauser |
| 2004 - 2007 | Principal Supervisor | Probiotics and Prebiotics as a Therapeutic Strategy for Inflammatory Bowel Disease | Doctor of Philosophy | Doctorate | Part Time | Dr Mark Geier |
| 2004 - 2007 | Co-Supervisor | Short-Chain Fatty Acid Modulation of Apoptosis in Gastric and Colon Cancer Cells' | Doctor of Philosophy | Doctorate | Full Time | Mr Geoffrey Matthews |
| 2003 - 2007 | Co-Supervisor | Detection of Small Intestinal Mucositis Utilising the Non-Invasive 13 C-Sucrose Breath Test' | Doctor of Philosophy | Doctorate | Part Time | Mrs Katie Tooley |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2016 - 2016 | Chair | Program Management Committee: Animal Science | University of Adelaide | Australia |
| 2015 - ongoing | Member | Research and Educational Development Committee | University of Adelaide | Australia |
| 2015 - ongoing | Member | Welfare, Health and Safety Committee - SAVS | University of Adelaide | Austria |
| 2015 - ongoing | Chair | Faculty HDR Committee | University of Adelaide | Australia |
| 2014 - ongoing | Chair | Research Committee - School of Animal and Veterinary Sciences | University of Adelaide | Australia |
| 2014 - ongoing | Member | Faculty of Sciences Research Committee | University of Adelaide | Australia |
| 2013 - ongoing | Member | Executive Committee - School of Animal and Veterinary Sciences | University of Adelaide | Australia |
| 2008 - ongoing | Co-Chair | HDR/Honours Committee - School of Animal and Veterinary Sciences | University of Adelaide | Australia |
| 2006 - ongoing | Founder | University Institutional Biosafety Committee | University of Adelaide | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2013 - 2018 | Editor-In-chief | Advances in Veterinary Science Research | Global Science and technology Foundation | Singapore |
| 2004 - ongoing | Associate Editor | Journal of Nutrition and Metabolism | - | United States |